Jinfang Zheng

机构：Hainan General Hospital · ORCID：0000-0002-0244-8461

发表论文 40 篇 · 总被引 657 次 · h-index 16

代表论文

• Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma (2020 · Pharmacological Research · 被引 77)
• ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway (2021 · Cell Death and Disease · 被引 73)
• Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 45)
• KDM5B promotes self‐renewal of hepatocellular carcinoma cells through the microRNA‐448–mediated YTHDF3/ITGA6 axis (2021 · Journal of Cellular and Molecular Medicine · 被引 39)
• LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p (2021 · Cellular Signalling · 被引 24)
• Protocol for a gallbladder cancer registry study in China: the Chinese Research Group of Gallbladder Cancer (CRGGC) study (2021 · BMJ Open · 被引 23)